Guest Opinions

Venture capitalists must adopt an ethical code of conduct or risk a social backlash and the devaluation of the venture capital market due to a lack of integrity, argues Dan Conner of Ascend Venture Capital.

Making seed investments into founders from underrepresented groups would have a more material impact for diverse founders than quotas, writes Sarah Barber, CEO of Jenson Funding Partners.

Entrepreneurial talent is undeniably diverse, but opportunity is not, and VCs are falling back on familiar patterns that overlook underserved communities.

Notable M&A deals in the two regions in 2021 included Tamer Group acquiring Mumzworld, Aleph Holding buying a majority stake in Connect Ads and Bevy scooping up Eventus.

Ian Connatty of British Patient Capital looks at the record-setting venture activity from 2021 and offers his take on what is to come this year.

With the topic of VCs and racism in the news, Jeff Bussgang of Flybridge Capital Partners addresses the question that is being posed: How do we explain the fact that only 1% of VC capital goes to Black founders?

How VCs and CVCs approach their work is different, writes Nicolas Sauvage of TDK Ventures.

Jason Schoettler of Calibrate Ventures talks about the potential for growth in healthtech and how it's attracting plenty of venture investors with their eyes on the $800bn US healthcare industry.

Scott Lenet of Touchdown Ventures talks about the crucial role of the corporate investment committee in venture capital.

Amit Anand of Jungle Ventures peers behind the curtain of Southeast Asia and calls it the world’s next great digital economy hub.